Caliper Life Sciences
Hopkinton, MA 01748
Share:
Fluorescent Imaging Agent enables personalized medicine research.
Aiding in early detection of disease, XenoLight(TM) RediJect(TM) COX-2 Probe specifically detects cyclooxygenase-2 (COX-2) biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications. With agent, researchers can also gain understanding of therapeutic efficacy in specific patient populations by monitoring key biomarker response to drug treatment.
Read More »Genomics Workstation provides automated liquid handling.
Designed for molecular biology applications, Zephyr Genomics Workstation includes pre-installed methods for automating nucleic acid purification chemistries, as well as standard Caliper methods for routine applications such as PCR setup and sample normalization. With partial tip loading capability, instrument can process 8-96 samples simultaneously. Unit's ultrasonic detector provides...
Read More »Caliper Life Sciences Ships 500th IVIS Imaging System
Therapeutic Focus Drives Record Q4 Placement of IVIS Systems HOPKINTON, Mass., January 31, 2008 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced the shipment of the 500th IVIS® molecular imaging system during the fourth quarter of 2007. Introduced in 2000, the IVIS molecular imaging system enables researchers to uniquely perform critical, noninvasive pre-clinical biological drug...
Read More »Caliper Introduces New Automation Offerings Paired with ACES Team
- New Ensemble and Reprise Systems Integrate Technologies from Multiple Vendors - HOPKINTON, Mass., Jan. 23 / -- Caliper Life Sciences, Inc. (NASDAQ:CALP) today introduced its new Ensemble and Reprise integrated systems, the first products conceived by its new Automation, Consulting, Engineering & Services (ACES) team. Unlike Caliper's industry leading Staccato systems, which feature primarily...
Read More »Caliper Life Sciences Launches 'Desktop Profiler' for In-house Kinase Profiling
Caliper Life Sciences Launches 'Desktop Profiler' for In-house Kinase Profiling Affordable, Ready-to-Use, Bench-top System Helps Therapeutic Labs Efficiently Qualify Drug Candidates HOPKINTON, Mass., Sept. 18 // -- Caliper Life Sciences, Inc. (NASDAQ:CALP) today launched the Desktop Profiler, a bench-top system for kinase profiling, at the Society for Biomolecular Sciences (SBS) conference and...
Read More »Automated Liquid Handling System has intuitive interface.
Powered by Maestro software, Zephyr is designed to eliminate labor-intensive manual processes. Automated, entry-level, bench top liquid handling workstation provides researchers with scaleable system that fits into space-constrained laboratories. Along with preconfigured preclinical, bioanalytical, and genomic applications, system comes with operator interface that guides researchers through...
Read More »Caliper Life Sciences Launches Xenogen In Vivo Imaging System with Advanced Fluorescent Detection Capability
IVIS Spectrum System Combines Advanced Fluorescent and Bioluminescent Imaging to Accelerate Preclinical Drug Discovery and Development HOPKINTON, Mass., Aug. 30 /Caliper Life Sciences, Inc. (NASDAQ:CALP), today unveiled the Xenogen IVIS Spectrum, the most flexible and advanced addition to the company's suite of in vivo imaging systems, at the Fifth Annual Meeting of the Society for Molecular...
Read More »Liquid Handling Workstation is programmed for 5 applications.
Suited for biotech and pharmaceutical users, Caliper Sciclone ALH 4000 integrates automated liquid handler with TwisterÃ-® II microplate handler within one system. Pre-programmed application templates for plate replication, serial dilution, assay set-up, hit picking, and DNA/RNA/protein purification allow immediate use of workstation and provide flexibility to switch between applications...
Read More »Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference
HOPKINTON, Mass., April 21, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET. A live webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CALP&item_id=3909124 or by...
Read More »Caliper Life Sciences Announces Date and Location of Its 2011 Annual Meeting of Stockholders
HOPKINTON, Mass., April 6, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that its 2011 Annual Meeting of Stockholders will be held on June 2, 2011, at 10:00 a.m. local time at its offices located at 68 Elm Street, Hopkinton, Massachusetts. The record date for Caliper stockholders entitled to vote at this meeting is April 15, 2011. About Caliper Life Sciences, Caliper Life...
Read More »Caliper Announces New Oncology Research Collaboration
Partners with Denver-based Catholic Health Initiatives to Develop Improved Methods for the Discovery of Cancer Drugs HOPKINTON, Mass., April 5, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has formed a research collaboration...
Read More »Fluorescent Imaging Agent enables personalized medicine research.
Aiding in early detection of disease, XenoLight(TM) RediJect(TM) COX-2 Probe specifically detects cyclooxygenase-2 (COX-2) biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications. With agent, researchers can also gain understanding of therapeutic efficacy in specific patient populations by monitoring key biomarker response to drug treatment.
Read More »Analysis of Caliper's Phase I EPA ToxCast(TM) Data Published in Leading Scientific Journal
o Initial ToxCast data from Caliper's in vitro assays reveal molecular targets with potential role in toxicity o $3.1 million of new EPA task orders support further expansion of Caliper's role in the ToxCast program HOPKINTON, Mass., February 24, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP), today announced that the results of its initial screening efforts under the U.S. Environmental...
Read More »Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing
Integration of DNA shearing technology with automation and microfluidics solutions simplifies next generation sequencing workflows and improves sample quality HOPKINTON, Mass., February 23, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris' acoustic DNA shearing platforms and Caliper's automation...
Read More »Caliper Life Sciences' Fourth Quarter and Fiscal Year 2010 Financial Results Conference Call Notice
HOPKINTON, Mass., February 11, 2011 -- Caliper Life Sciences, Inc. (NASDAQ: CALP) will conduct a conference call discussing the company's fourth quarter and fiscal year 2010 financial results at 5:00 pm Eastern (2:00 pm Pacific) on Wednesday, February 23, 2011. Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will...
Read More »Caliper Life Sciences Collaborates with University of Miami to Automate Next Generation Sequencing Workflows
o Caliper and University of Miami Collaborate to Develop Automated Protocols for Exome Capture and Sequencing Library Preparation HOPKINTON, Mass., February 3, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a collaboration with the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami. As part of this agreement, HIHG is working with Caliper to develop...
Read More »NuGEN and Caliper Partner to Eliminate Next-Gen Sequencing Sample Preparation Bottlenecks
- Methods are being developed to enable high-throughput, automated extraction, amplification, and preparation of difficult and compromised samples for next generation sequencing - SAN CARLOS, Calif. and HOPKINTON, Mass. -- NuGEN Technologies, Inc. and Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a co-marketing agreement for the development of automated methods for next generation...
Read More »Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
o Strong Fourth Quarter Produces 10% Organic Growth in 2010 o Company Provides Revenue Guidance for 2011 HOPKINTON, Mass., January 13, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced preliminary revenue for the fourth quarter of 2010 of approximately $36.0 million, which implies fiscal 2010 revenue of approximately $123.5 million, or 10% organic annual growth. The Company's...
Read More »